A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

Many of the randomized controlled trials for large vessel vasculitis with significant or nonsignificant outcomes show fragility, and measures do not vary with the risk for bias, drug type, or subtype.

Secondary analysis of Women’s Health Initiative data finds no elevated atherosclerotic cardiovascular risk in hormone therapy ...

Results of a new study support using semaglutide and tirzepatide to reduce risk in patients with cardiometabolic heart ...

Acupuncture needling is a safe and effective treatment option for older adults with chronic lower back pain, according to a September study published in the Journal of the American Medical Association ...

Tripling the weekly dose of semaglutide (Ozempic, Wegovy) resulted in greater weight loss compared with placebo in adults with obesity, both with and without type 2 diabetes, but did not increase the ...

Purpose To determine the effects of advanced spectacle lens technologies on changes in spherical equivalent of refraction ...

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

Researchers at the Indiana University School of Medicine, Eskenazi Health, Regenstrief Institute and other partners have ...

According to ESC, these recommendations respond directly to a request from the European Commission to provide expert advice ...